Who has invested in Corvus Pharmaceuticals?

OrbiMed Advisors are named among the investors backing Corvus Pharmaceuticals.

Corvus Pharmaceuticals Funding: $194M Raised, Series A

Corvus Pharmaceuticals funding overview

Corvus Pharmaceuticals is based in Burlingame, CA. Corvus Pharmaceuticals has raised $194M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2014. The round record for Corvus Pharmaceuticals runs through 2014; nothing later has been disclosed. Investors on record include OrbiMed Advisors.

Corvus Pharmaceuticals at a glance

Total raised: $194M
Latest round: Series A
Latest round date: December 2014
Headquarters: Burlingame, CA
Notable investors: OrbiMed Advisors

Frequently asked about Corvus Pharmaceuticals funding

How much has Corvus Pharmaceuticals raised?: Corvus Pharmaceuticals has raised $194M in total disclosed funding across the rounds on record.
Who has invested in Corvus Pharmaceuticals?: OrbiMed Advisors are named among the investors backing Corvus Pharmaceuticals.
What was the latest Corvus Pharmaceuticals funding round?: The most recent disclosed round is a Series A, announced in December 2014.
Where is Corvus Pharmaceuticals based?: Corvus Pharmaceuticals is based in Burlingame, CA.
When did Corvus Pharmaceuticals last raise?: The last disclosed Corvus Pharmaceuticals round closed in December 2014 at Series A.

Corvus Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlingame below to benchmark round size and investor mix.

Corvus Pharmaceuticals Funding: $194M Raised, Series A

Corvus Pharmaceuticals funding overview

Corvus Pharmaceuticals at a glance

Frequently asked about Corvus Pharmaceuticals funding

Companies related to Corvus Pharmaceuticals (28)

Browse related funding lists (3)